The combination of polymorphisms within MCP-1 and IL-1β associated with ulcerative colitis

International Journal of Immunogenetics

Volumn 36, Issue 3, 2009, Pages 135-139

  Li, K S ^b   Wang, B Y ^a   Liu, S Y ^a   Yao, S P ^a   Guo, L ^b   Mao, D W ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN ENGINEERING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE CONTROL; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINE CCL2; COLITIS, ULCERATIVE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 65649108090     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2009.00836.x     Document Type: Article

References (35)

1. Banks, C., Bateman, A., Payne, R., Johnson, P. Sheron, N. (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. Journal of Pathology, 199, 28. (Pubitemid 36054726)
2. Celik, Y., Dagli, U., Kiliç, M.Y., Törüner, M., Ozen, S.C., Ozkan, M. et al 2006) Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 41, 559.
3. Craggs, A., West, S., Curtis, A., Welfare, M., Hudson, M., Donaldson, P. et al 2001) Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England. Scandinavian Journal of Gastroenterology, 36, 1173. (Pubitemid 32917586)
4. Fiocchi, C. (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology, 115, 182. (Pubitemid 28307304)
5. di Giovine, F.S., Takhsh, E., Blakemore, A.I. Duff, G.W. (1992) Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Human Molecular Genetics, 1, 450.
6. González-Escribano, M.F., Torres, B., Aguilar, F., Rodríguez, R., García, A., Valenzuela, A. et al 2003) MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Human Immunology, 64, 741. (Pubitemid 36833211)
7. Grimm, M.C., Elsbury, S.K., Pavli, P. Doe, W.F. (1996) Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. Journal of Leukocyte Biology, 59, 804. (Pubitemid 26238475)
8. Halfvarson, J., Jess, T., Magnuson, A., Montgomery, S.M., Orholm, M., Tysk, C. et al 2006) Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflammatory Bowel Diseases, 12, 925. (Pubitemid 44498280)
9. Heresbach, D., Alizadeh, M., Dabadie, A., Le Berre, N., Colombel, J.F., Yaouanq, J. et al 1997) Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. The American Journal of Gastroenterology, 92, 1164. (Pubitemid 27304814)
10. Hong, S.B., Jin, S.Y., Park, H.J., Jung, J.H. Sim, W.Y. (2006) Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata. Journal of Korean Medical Science, 21, 90.
11. Hwang, I.R., Kodama, T., Kikuchi, S., Sakai, K., Peterson, L.E., Graham, D.Y. et al 2002) Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology, 123, 1793. (Pubitemid 35408303)
12. Kanemoto, K., Kawasaki, J., Miyamoto, T., Obayashi, H. Nishimura, M. (2000) Interleukin (IL)-1b, IL-1a, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Annals of Neurology, 47, 571. (Pubitemid 30261891)
13. Khan, W.I., Motomura, Y., Wang, H., El-Sharkawy, R.T., Verdu, E.F., Verma-Gandhu, M. et al 2006) Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. American Journal of Physiology. Gastrointestinal and Liver Physiology, 291, G803.
14. Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y. et al 2003) Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 656. (Pubitemid 36438080)
15. Lennard-Jones, J.E. (1989) Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 24, 2. (Pubitemid 20015811)
16. Ligumsky, M., Simon, P.L., Karmeli, F. Rachmilewitz, D. (1990) Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut, 31, 686.
17. Lima, G., Soto-Vega, E., Atisha-Fregoso, Y., Sánchez-Guerrero, J., Vallejo, M., Vargas-Alarcón, G. et al 2007) MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. Human Immunology, 68, 980.
18. MacDermott, R.P., Sanderson, I.R. Reinecker, H.C. (1998) The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflammatory Bowel Diseases, 4, 54. (Pubitemid 128699837)
19. Mahida, Y.R., Wu, K. Jewell, D.P. (1989) Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut, 30, 835. (Pubitemid 19167787)
20. Maury, C.P., Liljeström, M., Laiho, K., Tiitinen, S., Kaarela, K. Hurme, M. (2004) Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18. Journal of Internal Medicine, 256, 145. (Pubitemid 38998261)
21. Mazzucchelli, L., Hauser, C., Zgraggen, K., Wagner, H.E., Hess, M.W., Laissue, J.A. et al 1996) Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. Journal of Pathology, 178, 201. (Pubitemid 26057973)
22. McCormack, G., Moriarty, D., O'Donoghue, D.P., McCormick, P.A., Sheahan, K. Baird, A.W. (2001) Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflammation Research, 50, 491. (Pubitemid 32999710)
23. Nemetz, A., Nosti-Escanilla, M.P., Molnár, T., Köpe, A., Kovács, A., Fehér, J., Tulassay, Z., Nagy, F., García-González, M.A. Peña, A.S. (1999) IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics, 49, 527. (Pubitemid 29221785)
24. Ozyürek, A.R., Gürses, D., Ulger, Z., Levent, E., Bakiler, A.R. Berdeli, A. (2007) Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Turkish population and in Turkish patients with juvenile rheumatoid arthritis. Clinical Rheumatology, 26, 546. (Pubitemid 46359295)
25. Pallone, F. Monteleone, G. (2001) Mechanisms of tissue damage in inflammatory bowel disease. Current Opinion in Gastroenterology, 17, 307. (Pubitemid 32619970)
26. Reinecker, H.C., Loh, E.Y., Ringler, D.J., Mehta, A., Rombeau, J.L. MacDermott, R.P. (1995) Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology, 108, 40.
27. Rovin, B.H., Lu, L. Saxena, R. (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochemical and Biophysical Research Communications, 259, 344. (Pubitemid 29281234)
28. Stevens, C., Walz, G., Singaram, C., Lipman, M.L., Zanker, B., Muggia, A. et al 1992) Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Digestive Diseases and Sciences, 37, 818.
29. Szalai, C., Kozma, G.T., Nagy, A., Bojszkó, A., Krikovszky, D., Szabó, T. Falus, A. (2001) Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. The Journal of Allergy and Clinical Immunology, 108, 375. (Pubitemid 32881058)
30. Tabara, Y., Kohara, K., Yamamoto, Y., Igase, M., Nakura, J., Kondo, I. et al 2003) Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertension Research, 26, 677. (Pubitemid 37258653)
31. Tesch, G.H., Schwarting, A., Kinoshita, K., Lan, H.Y., Rollins, B.J. Kelley, V.R. (1999) Monocyte chemoattractant protein-1 promotes macrophage mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. The Journal of Clinical Investigation, 103, 73. (Pubitemid 29031165)
32. Truelove, S.C. Witts, L.J. (1955) Cortisone in ulcerative colitis. Final report on therapeutic trial. British Medical Journal, 2, 1041.
33. Uguccioni, M., Gionchetti, P., Robbiani, D.F., Rizzello, F., Peruzzo, S., Campieri, M. et al 1999) Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. The American Journal of Pathology, 155, 331. (Pubitemid 29370382)
34. Wahner, A.D., Sinsheimer, J.S., Bronstein, J.M. Ritz, B. (2007) Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Archives of Neurology, 64, 836. (Pubitemid 46919838)
35. Zhu, Y., Xu, Y., Wei, Y., Liang, W., Liao, M. Zhang, L. (2008) Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clinical Oncology (Royal College of Radiologists (Great Britain), 20, 207.